Prevent Hepatitis, Act Now
Globally, viral hepatitis kills 4,000 people every day. Each year an estimated 1.5 million people die due to hepatitis, which […]
Globally, viral hepatitis kills 4,000 people every day. Each year an estimated 1.5 million people die due to hepatitis, which […]
Cipla has launched a generic drug Sofosbuvir for treating chronic Hepatitis C under the brand name ‘Hepcvir’ in India. The […]
Nacto Pharma has received voluntary licence to manufacture the generic versions of US drug maker Gilead Sciences’ hepatitis C drug […]